[Federal Register Volume 70, Number 169 (Thursday, September 1, 2005)]
[Notices]
[Pages 52082-52083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17398]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Availability of Government-Owned Inventions; Available 
for Licensing

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 52083]]

SUMMARY: The Department of the Navy hereby gives notice of the 
availability of exclusive or partially exclusive license to practice 
worldwide under the following pending patent.
    Patent application Serial Numbers 11/152,340 and PCT/US05/21185 
entitled ``Method and Apparatus for Removing Mercury and Mercury 
Containing Particles from Dental Waste Water'' filed on June 15 and 16, 
2005. The present invention relates to the field of development of the 
removal of particulate metals, such as mercury or silver from dental 
waste-water using a self-contained mercury filtration cartridge for a 
single dental unit.
    Patent application Serial Numbers 11/152,340 and PCT/US05/21185 
entitled ``Hand-held Fluorescence Polarimeter'' filed on June 2, 2005. 
The present invention relates to a miniaturized, portable, hand-held 
apparatus for measuring the fluorescence polarization of a liquid 
sample.
    Patent application Serial Numbers 11/108,867 and PCT/US05/13255 
entitled ``Cloning and Expression of the Full Length 110 KDA Antigen of 
Orientia Tsutsugamushi to be Used as a Vaccine Component Against Scrub 
Typhus'' filed on April 19, 2005. The present invention relates to the 
protection against infection of Orientia tsutsugamushi.
    Patent application Serial Number 60/666,591 entitled ``Use of EEG 
to Measure Cerebral Changes During Computer-based Motion Sickness-
inducing Tasks'' filed on March 31, 2005. The present invention relates 
to an ability to pinpoint a specific neural marker that signals the 
early onset of motion sickness.
    Patent application Serial Number 60/650,972 entitled ``Diagnostic 
Assay for Orientia Tsutsugamushi by Detection of Responsive Gene 
Expression ``filed on February 9, 2005. The present invention relates 
to a method for the diagnosis of Orientia tsutsugamushi infection by 
measuring the increased or decreased expression of specific human genes 
following infection by microarray or polymerase chain reaction 
analysis.
    Patent application Serial Numbers 10/809,877 and PCT/US04/16880 
entitled ``A Rapid Immunoassay of Anthrax Protective Antigen in Vaccine 
Cultures and Bodily Fluids by Fluorescence Polarization'' filed on July 
27, 2004. The present invention relates to a competitive fluorescence 
method for estimating the concentration in a sample of Bacillus 
anthracis protein or specific antibody. The method contemplates the use 
of FLT, FRET or FP.
    Patent application Serial Number 10/855,325 entitled ``A Method for 
the Rapid Diagnosis of Infectious Disease by Detection and Quantitation 
of Microorganism Induced Cytokines'' filed on May 28, 2004. The present 
invention relates to a method for the diagnosis of latent infectious 
disease, such as Mycobacterium Tuberculosis, by estimating, the 
concentration of cytokine due to antibody-cytokine interaction or by 
dimerization of the cytokine.
    Patent application Serial Numbers 10/898,954 and PCT/US04/24252 
entitled ``Bowel Preparation for Virtual Colonoscopy'' filed on 
December 1, 2003. The present invention relates to an immunogenic 
composition and method of immunizing a subject against malarial disease 
comprising administering a priming immunization preparation containing 
an alphavirus replicon expressing a gene encoding a malarial antigen or 
combination of antigens and subsequently administering to the subject a 
boosting immunization preparation containing the malarial antigen(s) or 
antigen expression system containing the antigen(s).

DATES: Applications for an exclusive or partially exclusive license may 
be submitted at any time from the date of this notice.

ADDRESSES: Submit applications to the Office of Technology Transfer, 
Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 
20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave, Silver Spring, MD 20910-7500, telephone 301-319-7428 or e-mail at: 
<a href="/cdn-cgi/l/email-protection#8cffefe4e0edebe9e0efcce2e1feefa2e2edfaf5a2e1e5e0"><span class="__cf_email__" data-cfemail="3340505b5f5254565f50735d5e41501d5d52454a1d5e5a5f">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Any license granted shall comply with 35 
U.S.C. 209 and 37 CFR Part 404. Applications will be evaluated 
utilizing the following criteria: (1) Ability to manufacture and market 
the technology; (2) manufacturing and marketing ability; (3) time 
required to bring technology to market and production rate; (4) 
royalties; (5) technical capabilities; and (6) small business status.

    Dated: August 26, 2005.
I.C. Le Moyne Jr.,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Alternate 
Federal Register Liaison Officer.
[FR Doc. 05-17398 Filed 8-31-05; 8:45 am]
BILLING CODE 3810-FF-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>